US Stem Cell Inc (USRM)

[TheHungryHippo]

$USRM Currently Market Value of: $1,280,834 w/ pps of .021495 @ of March 15th, 2017

Undervalued is an Understatement,

ANYONE DUMB ENOUGH TO SELL HERE,

Will regret it.

USRM has insurance to cover anything that could go wrong in a clinical trial!

Their VOLUNTARY PATIENTS must sign WAIVERS before they enter trials!!!

That article did NOTHING except PUT MORE EYES on Our SOLID DD and Company!

CRAPPY ARTICLE ON 3 WOMEN DEBUNKED BY BULLS!

On September 17, 2015, a product liability lawsuit was filed in Broward County, specifically Patsy Bade v. Bioheart, Inc. US Stem Cell Clinics LLC, Aleiandro Perez, ARNP, and Shareen Greenbaum, M.D., and on November 30, 2015, a product liability lawsuit was filed in Broward County, specifically Elizabeth Noble v. Bioheart, Inc. US Stem Cell Clinics LLC, Aleiandro Perez, ARNP, and Shareen Greenbaum, M.D. During the year ended December 31, 2016, both matters settled by the Company’s insurance policy with no additional cost to the Company.

USRM DOES NOT PARTICIPATE IN THERAPY FOR BLINDNESS ANYMORE.

AND THEIR INSURANCE COVERS EVERYTHING INVOLVED WITH CLINICAL TRIALS!



Clinical trial expenses include costs related to the culture and preparation of cells in connection with our clinical trials, costs of contract research, costs of clinical trial facilities, costs of delivery systems, salaries and related expenses for clinical personnel and insurance costs.

Marketing, general and administrative expenses were $3,264,107 in 2016, a decrease of $544,521 from marketing, general and administrative expenses of $3,808,628 in 2015. The decrease in marketing, general and administrative expenses is attributable, in part, to reductions in legal fees, salaries and insurance expenses.

At present, there is no pending litigation or proceeding involving any of our directors or executive officers as to which indemnification is required or permitted and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.

We maintain a liability insurance policy, pursuant to which our directors and officers may be insured against liability they incur for serving in their capacities as directors and officers of our company, including liabilities arising under the Securities Act or otherwise.